Loading...
Rational HIV immunogen design to target specific germline B cell receptors
Vaccine development to induce broadly neutralizing antibodies (bNAbs) against HIV-1 is a global health priority. Potent VRC01-class bNAbs against the CD4 binding site of HIV gp120 have been isolated from HIV-1-infected individuals; however, such bNAbs have not been induced by vaccination. Wild-type...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3689846/ https://ncbi.nlm.nih.gov/pubmed/23539181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.1234150 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|